35
Growth Score in past quarter
pts
Heat Score 35 in past quarter
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1354256
Concordia UK develops, licenses, and markets generic pharmaceutical products.

AMCo
About the Company
Concordia UK develops, licenses, and markets generic pharmaceutical products. It also manages and markets generic and branded pharmaceutical products of other companies.
Concordia UK markets products through its sales, marketing, and distribution team in Europe. It began operation as Focus Pharmaceuticals in 2002.
Concordia UK's
headquarters is in London in the United Kingdom. It operates as a subsidiary of Amdipharm Mercury Company as of September 30, 2014.